Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
ClinicalTrials.gov study NCT00148668. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02984683. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT01091454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00291577. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
ClinicalTrials.gov study NCT00751101. IPD Sharing: NO. Countries: 1. Publications: 0.
Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
ClinicalTrials.gov study NCT00451555. IPD Sharing: YES. Countries: 5. Publications: 0.
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
ClinicalTrials.gov study NCT04862585. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients
ClinicalTrials.gov study NCT04045392. IPD Sharing: Not stated. Countries: 0. Publications: 1.
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
ClinicalTrials.gov study NCT06756932. IPD Sharing: YES. Countries: 3. Publications: 0.
Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer
ClinicalTrials.gov study NCT00739063. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
ClinicalTrials.gov study NCT02983604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02562378. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
ClinicalTrials.gov study NCT00318513. IPD Sharing: Not stated. Countries: 1. Publications: 45.
Studying The Association Between Environmental Exposure to PFAS and Breast Cancer in Assiut Governorate- Egypt
ClinicalTrials.gov study NCT06457282. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer
ClinicalTrials.gov study NCT00726180. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00068588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01525966. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer
ClinicalTrials.gov study NCT06777537. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Emotions Immunology and Breast Cancer
ClinicalTrials.gov study NCT03609671. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
UCLA Breast Cancer Survivor Health Promotion Research Study
ClinicalTrials.gov study NCT05113485. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.